- Email: [email protected]
Big future for nano biomedical devices says US analyst
news
Big future for nano biomedical devices says US analyst A US business analysis house is claiming that the global nanoscale biomedical devices market will grow by about 35 per cent year on year up to 2007. Molecular modelling is also set to expand, says Connecticutbased Business Communications Company (BCC), but by a more modest 5.8 per cent average annual growth. The BCC estimates that revenues from nanoscale biomedical device sales will top $1 billion in four years. Their projection comes despite the fact that Food and Drug Administration involvement in the Unites
States and similar legislative rules in Europe and other countries mean that exhaustive testing is the norm in the development of pharmaceuticals and related delivery systems. Putting a figure on time and development costs for a new pharmaceutical is difficult, but industry analysts commonly use a rule-ofthumb measure of $600 million to $800 million and some 12 years for an "average" drug. BCC recognises that although the market has huge potential - some commentators estimate it up to $1 trillion eventually - it is
A finer grind with Union Process
GKN puts positive spin on decline in sales
going to take time for them to be commercialised. They will eventually be employed as drugs or drug delivery systems. Nanoscale biomedical devices, says the BCC, could play a role in attempts to create artificial cells and artificial organs such as retinal implants. The future for molecular modelling software is less certain. For although BCC foresees growth of around 6 per cent per year, the analysts recognise that there will be competition from publicly available software from academic sources. "Free is a hard price point to beat," they conclude.
GKN put a positive spin on its PM businesses for the first half of 2003 despite a dip in sales to £318 million ($512 million). The company attributed the decrease to the dollar’s decline against the Pound and the Euro. Sales levels remained stable in the face of reduced demand from markets in North America and Western Europe. The division is heavily dependent on U.S. automotive markets. Excluding the impact of currency fluctuations profits increased slightly. European businesses performed well along with improved contributions from operations in South America and India. Hoeganaes also gained. Research and development will be concentrated on a new development centre in Germany, scheduled to open in 2004.
Copper gleams TOTAL world shipments of copper powder came close to 70 000 short tons last year. North America took 24 000 tons; Europe and Asia each took 20 000 tons and other countries 5 000 short tons. Bearing manufacture accounts for more than 50 per cent of the total. According to consultant Pierre Taubembalt there will be further consolidations among copper powder makers in North America. Future growth markets include iron powder preblends, lock parts, plumbing fixtures and decorative parts.
News in brief ISO win PAKISTANI PM company Adamjee Engineering of Karachi has been certified to ISO 9001. Mill manufacturer Union Process has introduced a small media mill to its range of attrition equipment featuring a revolutionary highcirculation design for super-fine grinding. The QC-150's rotor creates strong centrifugal and shearing forces resulting in efficient grinding and narrow particle size distribution.
8
MPR September 2003
Talking aluminium ALUMINIUM 2004, the fifth world trade fair and conference, is to be held 22 - 24
September at the Essen Exhibition Centre in Germany.
Test data THE 2003 edition of Standard Test Methods for Metal Powders and Powder Metallurgy Products is available from the Metal Powder Industries Federation. The new volume contains 34 standards.
metal-powder.net
Big future for nano biomedical devices says US analyst A US business analysis house is claiming that the global nanoscale biomedical devices market will grow by about 35 per cent year on year up to 2007. Molecular modelling is also set to expand, says Connecticutbased Business Communications Company (BCC), but by a more modest 5.8 per cent average annual growth. The BCC estimates that revenues from nanoscale biomedical device sales will top $1 billion in four years. Their projection comes despite the fact that Food and Drug Administration involvement in the Unites
States and similar legislative rules in Europe and other countries mean that exhaustive testing is the norm in the development of pharmaceuticals and related delivery systems. Putting a figure on time and development costs for a new pharmaceutical is difficult, but industry analysts commonly use a rule-ofthumb measure of $600 million to $800 million and some 12 years for an "average" drug. BCC recognises that although the market has huge potential - some commentators estimate it up to $1 trillion eventually - it is
A finer grind with Union Process
GKN puts positive spin on decline in sales
going to take time for them to be commercialised. They will eventually be employed as drugs or drug delivery systems. Nanoscale biomedical devices, says the BCC, could play a role in attempts to create artificial cells and artificial organs such as retinal implants. The future for molecular modelling software is less certain. For although BCC foresees growth of around 6 per cent per year, the analysts recognise that there will be competition from publicly available software from academic sources. "Free is a hard price point to beat," they conclude.
GKN put a positive spin on its PM businesses for the first half of 2003 despite a dip in sales to £318 million ($512 million). The company attributed the decrease to the dollar’s decline against the Pound and the Euro. Sales levels remained stable in the face of reduced demand from markets in North America and Western Europe. The division is heavily dependent on U.S. automotive markets. Excluding the impact of currency fluctuations profits increased slightly. European businesses performed well along with improved contributions from operations in South America and India. Hoeganaes also gained. Research and development will be concentrated on a new development centre in Germany, scheduled to open in 2004.
Copper gleams TOTAL world shipments of copper powder came close to 70 000 short tons last year. North America took 24 000 tons; Europe and Asia each took 20 000 tons and other countries 5 000 short tons. Bearing manufacture accounts for more than 50 per cent of the total. According to consultant Pierre Taubembalt there will be further consolidations among copper powder makers in North America. Future growth markets include iron powder preblends, lock parts, plumbing fixtures and decorative parts.
News in brief ISO win PAKISTANI PM company Adamjee Engineering of Karachi has been certified to ISO 9001. Mill manufacturer Union Process has introduced a small media mill to its range of attrition equipment featuring a revolutionary highcirculation design for super-fine grinding. The QC-150's rotor creates strong centrifugal and shearing forces resulting in efficient grinding and narrow particle size distribution.
8
MPR September 2003
Talking aluminium ALUMINIUM 2004, the fifth world trade fair and conference, is to be held 22 - 24
September at the Essen Exhibition Centre in Germany.
Test data THE 2003 edition of Standard Test Methods for Metal Powders and Powder Metallurgy Products is available from the Metal Powder Industries Federation. The new volume contains 34 standards.
metal-powder.net